- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Endocrine therapy in prostate cancer: Time for reappraisal of risks, benefits and cost-effectiveness? - Abstract
February 14, 2013
How surgical innovation reduced death and suffering from prostate cancer - Abstract
February 14, 2013
Early results of prostate cancer radiation therapy: An analysis with emphasis on research strategies to improve treatment delivery and outcomes - Abstract
February 14, 2013
A review of emerging strategies for optimizing the clinical impact of immunotherapeutic agents in prostate cancer
February 14, 2013
Landmark survey of prostate biopsies confirms sampling standard
February 14, 2013
Clinical appraisal of abiraterone in the treatment of metastatic prostatic cancer: Patient considerations, novel opportunities, and future directions - Abstract
February 13, 2013
Dosimetric assessment of prostate cancer patients through principal component analysis (PCA) - Abstract
February 13, 2013
Risk stratification after biochemical failure following curative treatment of locally advanced prostate cancer: Data from the TROG 96.01 trial - Abstract
February 13, 2013
Changes in serum prostate-specific antigen levels and the identification of prostate cancer in a large managed care population - Abstract
February 13, 2013
Masculinities and patient perspectives of communication about active surveillance for prostate cancer - Abstract
February 13, 2013
Familial prostate cancer: The damage done and lessons learnt - Abstract
February 12, 2013
Edema-induced changes in tumor cell surviving fraction and tumor control probability in 131Cs permanent prostate brachytherapy implant patients - Abstract
February 12, 2013
Exercise maintains sexual activity in men undergoing androgen suppression for prostate cancer: A randomized controlled trial - Abstract
February 12, 2013
Active surveillance for prostate cancer: Overview and update - Abstract
February 12, 2013